Principal investigator Lewis Romer, MD, of Johns Hopkins Medicine joined us to discuss the actively-recruiting MoD PAH trial assessing mono vs dual therapy for pediatric PAH. Lewis Romer, MD, ...

Neffy was first approved in September 2024 to treat type 1 allergic reactions in patients who weigh at least 66 lbs (33 kg). ARS Pharmaceuticals has announced new developments for neffy (epinephrine ...

Results from a recent study revealed that compulsive and addictive elements can contribute to the risk of disordered eating. Study investigator Susan Carnell, PhD, explains these findings. Carnell is ...

Positive interim data was reported from the ENERGY 1 trial and Expanded Access Program that featured a total of 5 infants and 1 child. Positive interim data from Inozyme Pharma has been reported for ...

The REACH Institute awards 50 cognitive behavioral therapy (CBT) scholarships to primary care clinicians nationwide to bridge critical gaps in pediatric mental health care ...

Lifestyle medicine and mental health management in pediatric primary care promote positive health and holistic well-being. Psychopharmacologic agents used in the pediatric population from the ...

Lifestyle medicine and mental health management in pediatric primary care promote positive health and holistic well-being.